These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9808419

  • 1. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
    Siu LK, Cheng WL, Ho PL, Ng WS, Chau PY, Lo JY.
    APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
    [Abstract] [Full Text] [Related]

  • 2. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre.
    Wong JS, Mohd Azri ZA, Subramaniam G, Ho SE, Palasubramaniam S, Navaratnam P.
    Malays J Pathol; 2003 Dec; 25(2):113-9. PubMed ID: 16196367
    [Abstract] [Full Text] [Related]

  • 3. [Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
    Cisterna R, Fresnadillo MJ, García-Rodríguez JA, Gobernado M, Martín R, Perea E, Picazo J.
    Rev Esp Quimioter; 1998 Sep; 11(3):245-50. PubMed ID: 9795311
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S, Marre R.
    Infection; 1991 Sep; 19(2):106-9. PubMed ID: 1646771
    [Abstract] [Full Text] [Related]

  • 5. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
    Oliver A, Pérez-Vázquez M, Martínez-Ferrer M, Baquero F, De Rafael L, Cantón R.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
    [Abstract] [Full Text] [Related]

  • 6. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM, Distler AM, Bonomo RA.
    Biochemistry; 2007 Oct 09; 46(40):11361-8. PubMed ID: 17848099
    [Abstract] [Full Text] [Related]

  • 7. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 09; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 8. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Feb 09; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 9. Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.
    Banic S.
    APMIS; 2006 Jan 09; 114(1):3-9. PubMed ID: 16499654
    [Abstract] [Full Text] [Related]

  • 10. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA, Badaracco A, Ayala J, Rodríguez C, Famiglietti A, Gutkind GO.
    Rev Argent Microbiol; 2014 Jan 09; 46(3):210-7. PubMed ID: 25444130
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibilities of Escherichia coli and Klebsiella spp. to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Kacmaz B, Sultan N.
    Jpn J Infect Dis; 2007 Jul 09; 60(4):227-9. PubMed ID: 17642541
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov 09; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 13. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N, Diri MC, Türkyilmaz FR.
    Mikrobiyol Bul; 1987 Oct 09; 21(4):284-8. PubMed ID: 3332705
    [Abstract] [Full Text] [Related]

  • 14. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V, Bozdogan B, Jacobs MR, Ubukata K, Appelbaum PC.
    J Antimicrob Chemother; 2003 Dec 09; 52(6):1018-21. PubMed ID: 14585854
    [Abstract] [Full Text] [Related]

  • 15. An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria.
    Siu LK, Lo JY, Cheng WL, Ho PL, Ng WS, Chau PY.
    APMIS; 1999 Jul 09; 107(7):703-8. PubMed ID: 10440070
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.
    Fuchs PC, Barry AL, Pfaller MA, Hardy DJ, McLaughlin JC, Gerlach EH.
    Diagn Microbiol Infect Dis; 1993 Jul 09; 17(2):171-5. PubMed ID: 8243040
    [Abstract] [Full Text] [Related]

  • 17. Resistance pattern of extended-spectrum beta-lactamase producing Enterobacteriaceae isolates.
    Tuchiluş C, Poiată A, Bosnea D, Bădicuţ I, Buiuc D.
    Roum Arch Microbiol Immunol; 2002 Jul 09; 61(4):285-91. PubMed ID: 15055262
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B, Setacci D, Perilli M, Franchino L, Franceschini N, Agnifili A, Rossolini GM, Amicosante G.
    Int J Antimicrob Agents; 2004 May 09; 23(5):480-6. PubMed ID: 15120727
    [Abstract] [Full Text] [Related]

  • 19. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
    Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L, Portuguese Resistance Study Group.
    J Antimicrob Chemother; 2007 Dec 09; 60(6):1370-4. PubMed ID: 17913717
    [Abstract] [Full Text] [Related]

  • 20. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct 09; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.